BD (company)

Charles Bodner Joins CSafe Global as Chief Financial Officer

Wednesday, September 15, 2021 - 5:17pm

DAYTON, Ohio, Sept. 15, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner has joined the company's executive team as Chief Financial Officer. 

Key Points: 
  • CSafe Global has hired Charles Bodner as CFO following Patrick Schafer's promotion to CEO in 2020.
  • DAYTON, Ohio, Sept. 15, 2021 /PRNewswire/ -- CSafe Global , the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner has joined the company's executive team as Chief Financial Officer.
  • Prior to joining CSafe Global, he held senior level positions with Sanofi-Aventis, Schering-Plough, AstraZeneca, Becton Dickinson and Bioclinica.
  • "After helping Bioclinica successfully complete its merger with ERT, I am very excited to be joining the CSafe team," Bodner said.

Charles Bodner Joins CSafe Global as Chief Financial Officer

Wednesday, September 15, 2021 - 4:42pm

DAYTON, Ohio, Sept. 15, 2021 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner has joined the company's executive team as Chief Financial Officer. 

Key Points: 
  • CSafe Global has hired Charles Bodner as CFO following Patrick Schafer's promotion to CEO in 2020.
  • DAYTON, Ohio, Sept. 15, 2021 /PRNewswire/ -- CSafe Global , the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today that Charles ('Chuck') Bodner has joined the company's executive team as Chief Financial Officer.
  • Prior to joining CSafe Global, he held senior level positions with Sanofi-Aventis, Schering-Plough, AstraZeneca, Becton Dickinson and Bioclinica.
  • "After helping Bioclinica successfully complete its merger with ERT, I am very excited to be joining the CSafe team," Bodner said.

Help Lightning Integrates with ServiceNow to Support Complex Service Scenarios Using Remote Assistance Software

Wednesday, September 8, 2021 - 2:00pm

"The need for remote assistance software has grown exponentially as companies look for ways to improve resolution times and customer satisfaction simultaneously," said Gary York, CEO of Help Lightning.

Key Points: 
  • "The need for remote assistance software has grown exponentially as companies look for ways to improve resolution times and customer satisfaction simultaneously," said Gary York, CEO of Help Lightning.
  • Using Help Lightning's unique approach to customer support, ServiceNow agents can virtually connect with a customer in one collaborative work environment.
  • To learn more about how Help Lightning's remote visual assistance software innovates support for ServiceNow customers, visit store.servicenow.com .
  • Help Lightning, Inc. provides remote assistance software to hundreds of companies across a variety of industries with over 60,000 users in over 90 countries.

Encompass Health appoints Christopher Reidy to its Board of Directors

Tuesday, September 7, 2021 - 12:14pm

BIRMINGHAM, Ala., Sept. 7, 2021 /PRNewswire/ --Encompass Health Corporation (NYSE: EHC) today announced the appointment of Christopher R. Reidy to the Encompass Health board of directors, effective October 1, 2021.

Key Points: 
  • BIRMINGHAM, Ala., Sept. 7, 2021 /PRNewswire/ --Encompass Health Corporation (NYSE: EHC) today announced the appointment of Christopher R. Reidy to the Encompass Health board of directors, effective October 1, 2021.
  • This appointment will expand the Encompass Health board to 15 director seats as part of its ongoing succession planning.
  • Mr. Reidy joins the Encompass Health board with significant experience in healthcare, finance, accounting, strategic planning, and information technology and security.
  • "We are pleased that Chris, an extremely accomplished and respected executive, will bring a wide and diverse range of skills and experiences to the Encompass Health Board," said Leo I. Higdon Jr., Chairman of Encompass Health's Board of Directors.

Thompson Street Capital Partners Acquires Vector Laboratories

Tuesday, September 7, 2021 - 11:00am

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced it has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ: MRVI).

Key Points: 
  • Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced it has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ: MRVI).
  • Vector Laboratories is a manufacturer of labeling and visual detection reagents for life science researchers doing tissue-based protein detection and characterization.
  • Were excited to partner with Thompson Street Capital Partners, as their knowledge of the research reagents space provides an immediate opportunity to position the Company for both organic and strategic growth and take advantage of what we believe are tremendous opportunities in the marketplace.
  • Thompson Street Capital Partners ( www.tscp.com ) is a St. Louis-based private equity firm focused on investing in founder-led middle market businesses in the Life Sciences & Healthcare, Software & Technology, and Business and Consumer Services and Products sectors.

Cell Culture Market 2021-2025 | Post-Pandemic Industry Planning Structure |17000+ Technavio Reports

Wednesday, September 1, 2021 - 4:30am

COVID-19 Impact Analysis on Cell Culture Market can now be gained through our report.

Key Points: 
  • COVID-19 Impact Analysis on Cell Culture Market can now be gained through our report.
  • With the gradual recovery of markets from the aftermath of the COVID-19 pandemic, the cell culture market is likely to witness a positive impact during the forecast period.
  • Bio-Techne Corp.-The company offers a comprehensive range of cell culture reagents including media and supplements, FBS, basement membrane extracts, and custom cell culture services.
  • Get a report snapshot here to get a detailed market share analysis of market participants during COVID-19 lockdown:
    The cell culture market is segmented as below:

Arterial Blood Gas Kits Market Forecast to 2028 - ResearchAndMarkets.com

Thursday, August 26, 2021 - 12:10pm

The "Arterial Blood Gas Kits Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (1mL (Syringe Volume), 3mL (Syringe Volume), and Others); End User (Hospitals, Clinics, and Others), and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Arterial Blood Gas Kits Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (1mL (Syringe Volume), 3mL (Syringe Volume), and Others); End User (Hospitals, Clinics, and Others), and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Arterial Blood Gas Kits market.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Arterial Blood Gas Kits market, thereby allowing players across the value chain to develop effective long-term strategies.

BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results

Wednesday, August 25, 2021 - 9:10pm

The test will initially be made available to businesses, schools and governments looking to provide a self-testing option for employees or students.

Key Points: 
  • The test will initially be made available to businesses, schools and governments looking to provide a self-testing option for employees or students.
  • The BD Veritor At-Home COVID-19 Test will use a simple, pain-free nasal swab and an easy-to-use mobile app from Scanwell Health that yields reliable test results in 15 minutes.
  • The mobile device's camera is then used to capture, analyze and interpret the results, which eliminates the human subjectivity of a visually read test.
  • The BD Veritor At-Home COVID-19 Test has not been FDA cleared or approved; but has been authorized by FDA under EUA.

Ricoh Signs Expansion Agreement with Help Lightning to Reinforce Global Commitment to Customer Experience

Wednesday, August 11, 2021 - 2:00pm

By expanding its Help Lightning relationship from the US to other regions including EMEA, Asia Pacific, and Latin America, Ricoh will leverage consistent technology to support global customers with a focus on constantly enhancing the customer experience.

Key Points: 
  • By expanding its Help Lightning relationship from the US to other regions including EMEA, Asia Pacific, and Latin America, Ricoh will leverage consistent technology to support global customers with a focus on constantly enhancing the customer experience.
  • Help Lightning's on-site and self-help remote visual assistance capabilities are a reassurance to Ricoh customers that their equipment will experience increased uptime.
  • Prior to the global implementation, Ricoh USA, Inc. introduced Help Lightning's technology via the company's "Early Adopters" program.
  • Through our extensive onboarding program, Help Lightning proved the benefits of its software, leading Ricoh to expand the service globally."

Stevanato Group to Report Second Quarter Financial Results on August 19

Wednesday, August 11, 2021 - 12:54pm

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the second quarter of fiscal year 2021 on Thursday, August 19, 2021.

Key Points: 
  • Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the second quarter of fiscal year 2021 on Thursday, August 19, 2021.
  • The Company will host a conference call to discuss the financial results at 8:30 a.m. Eastern Time (14:30 CET) on August 19, 2021.
  • Management will refer to a slide presentation during the call, which will be made available on the day of the call.
  • To view the presentation, please visit the Financial Results page, under the Company's Investor Relations section of its website.